Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma

Abstract

In the current study, low-dose dexamethasone and cyclophosphamide demonstrated efficacy as salvage therapy in the treatment of patients with hormone-refractory prostate carcinoma.